Nikolova P V, Wong K B, DeDecker B, Henckel J, Fersht A R
Cambridge University Chemical Laboratory and Cambridge Centre for Protein Engineering, MRC Centre, Hills Road, Cambridge CB2 2QH, UK.
EMBO J. 2000 Feb 1;19(3):370-8. doi: 10.1093/emboj/19.3.370.
The core domain of p53 is extremely susceptible to mutations that lead to loss of function. We analysed the stability and DNA-binding activity of such mutants to understand the mechanism of second-site suppressor mutations. Double-mutant cycles show that N239Y and N268D act as 'global stability' suppressors by increasing the stability of the cancer mutants G245S and V143A-the free energy changes are additive. Conversely, the suppressor H168R is specific for the R249S mutation: despite destabilizing wild type, H168R has virtually no effect on the stability of R249S, but restores its binding affinity for the gadd45 promoter. NMR structural comparisons of R249S/H168R and R249S/T123A/H168R with wild type and R249S show that H168R reverts some of the structural changes induced by R249S. These results have implications for possible drug therapy to restore the function of tumorigenic mutants of p53: the function of mutants such as V143A and G245S is theoretically possible to restore by small molecules that simply bind to and hence stabilize the native structure, whereas R249S requires alteration of its mutant native structure.
p53的核心结构域极易发生导致功能丧失的突变。我们分析了此类突变体的稳定性和DNA结合活性,以了解第二位点抑制突变的机制。双突变循环表明,N239Y和N268D通过增加癌症突变体G245S和V143A的稳定性而作为“全局稳定性”抑制子——自由能变化是累加的。相反,抑制子H168R对R249S突变具有特异性:尽管使野生型不稳定,但H168R对R249S的稳定性几乎没有影响,但能恢复其对gadd45启动子的结合亲和力。R249S/H168R和R249S/T123A/H168R与野生型和R249S的NMR结构比较表明,H168R逆转了R249S诱导的一些结构变化。这些结果对恢复p53致瘤突变体功能的可能药物治疗具有启示意义:理论上,通过简单结合并稳定天然结构的小分子有可能恢复V143A和G245S等突变体的功能,而R249S则需要改变其突变的天然结构。